Asklepios BioPharmaceutical, Inc.

ASKBIO

Biotechnological product, namely, viral DNA vector, for delivery of genes and other materials, namely, RNA and transcriptional targeting promoters, to a biological cell for medical purposes;ASK BIOTECHNOLOGICAL;

NEAAV

Vaccines; DNA based vaccines; DNA extracts, namely, nucleic acid sequences and chemical reagents for medical use; Therapeutic DNA, namely, nucleic acid sequences and chemical reagents for medical and veterinary purposes; Biotechnological product, namely, viral DNA vector, for delivery of genes and other materials, namely, RNA and transcriptional targeting promoters, to a biological cell for medical purposes; DNA for production of viral vectors;Chemical preparations, enzymes and DNA for the preparation of nucleic acid for scientific research; chemicals for use in the preparation and creation of DNA extracts and cassettes for scientific and industrial purposes; enzymes for use in the preparation and creation of DNA extracts and cassettes for scientific and industrial purposes; DNA extracts and cassettes for scientific and research use; DNA extracts for use in agri-biotechnology and nanotechnology; Biological and biochemical reagents forming a gene analysis system-, namely, RNA polymerase, DNA plasmid vectors and RNA markers; Diagnostic reagents for scientific or research purposes, namely, a kit including a DNA plasmid vectors;Scientific and technological services, namely, research and design in the field of DNA research and development; chemical and biological analysis and research services; scientific research in the field of DNA; scientific research and development in the field of creation of DNA extracts; scientific research, analysis, design and development relating to DNA based pharmaceutical drugs and therapies; scientific research and development in the fields of gene therapy, diagnostics, agri-biotechnology and nanotechnology; consultancy in the fields of gene therapy, diagnostics, agri-biotechnology, nano technology and DNA analysis;

NEDNA

Vaccines; DNA based vaccines; DNA extracts, namely, nucleic acid sequences and chemical reagents for medical use; Therapeutic DNA, namely, nucleic acid sequences and chemical reagents for medical and veterinary purposes; Biotechnological product, namely, viral DNA vector, for delivery of genes and other materials, namely, RNA and transcriptional targeting promoters, to a biological cell for medical purposes; DNA for production of viral vectors;Chemical preparations, enzymes and DNA for the preparation of nucleic acid for scientific research; chemicals for use in the preparation and creation of DNA extracts and cassettes for scientific and industrial purposes; enzymes for use in the preparation and creation of DNA extracts and cassettes for scientific and industrial purposes; DNA extracts and cassettes for scientific and research use; DNA extracts for use in agri-biotechnology and nanotechnology; Biological and biochemical reagents forming a gene analysis system-, namely, RNA polymerase, DNA plasmid vectors and RNA markers; Diagnostic reagents for scientific or research purposes, namely, a kit including a DNA plasmid vectors;Scientific and technological services, namely, research and design in the field of DNA research and development; chemical and biological analysis and research services; scientific research in the field of DNA; scientific research and development in the field of creation of DNA extracts; scientific research, analysis, design and development relating to DNA based pharmaceutical drugs and therapies; scientific research and development in the fields of gene therapy, diagnostics, agri-biotechnology and nanotechnology; consultancy in the fields of gene therapy, diagnostics, agri-biotechnology, nano technology and DNA analysis;